PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Ranolazine - Angina
PAD Profile : Ranolazine - Angina
Brand Names Include :
Ranexa
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Isosorbide mononitrate
- Ivabradine
- Diltiazem hydrochloride
- Nifedipine
- Glyceryl trinitrate
- Amlodipine
- Verapamil hydrochloride
- Nicorandil
- Atenolol
- Bisoprolol fumarate
- Carvedilol
- Isosorbide dinitrate
- Metoprolol tartrate
- Propranolol hydrochloride
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Shared Care
31 March 2020
Committee Recommendations
Date
Committee Name
Narrative
01 February 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
A scheduled review of the expired Amber Shared Care document has taken place and was approved at PCN. The place in therapy of Ranolazine for stable Angina had previously been discussed by the PCN in March 2012 and the policy statement from those discussions still stands. See below for approved AMBER Shared Care and policy statement (PCN 13-2012) from previous discussions.
Associated BNF Codes
02. Cardiovascular System
02.06.03. Other antianginal drugs